Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 22, 2026, 18:05Renew Your ESHRE Membership Today and Get the Knowledge You Need – ESHRE
-
Mar 22, 2026, 18:02Placenta Previa or PAS? Test Your Diagnostic Skills – ISUOG
-
Mar 22, 2026, 17:56Zuzana Santamaria: Addressing HPV Stigma and Partner Management in Gynecologic Oncology
-
Mar 22, 2026, 14:33Arsene Mekinian: Paris Hosts 3rd International Congress on Recurrent Pregnancy Loss
-
Mar 22, 2026, 14:24Secure Your Spot for the Upcoming Virtual Symposium – Ryvex
-
Mar 22, 2026, 13:14Nicola Pozzi: New Mechanism to Reduce Thrombus Formation Without Increasing Bleeding Risk
-
Mar 22, 2026, 13:03Aumatma Simmons: How Is Your Practice Approaching Post-Miscarriage Diagnostic Protocols?
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation